Category: Fundamentals For stable patients with new-onset or newly recurrent atrial fibrillation (a duration of 48 hours or less) or in those with therapeutic anticoagulation, cardioversion is an option unless valve disease, hypokalemia, or digitalis toxicity exist.
No comments :
Post a Comment